DSP Healthcare Fund vs Nippon India Pharma Fund compare
Nippon India Pharma Fund-Growth Plan-Growth Option
DSP Healthcare Fund - Regular Plan - Growth
Chart Comparison
Overview
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Fund | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Investment Plan | Growth | Growth |
Level of Risk | Very High | Very High |
Asset Size (Cr) | ₹8352 Cr | ₹2961 Cr |
Min Investment | ₹5000 | ₹100 |
Min SIP Invesment | ₹500 | ₹100 |
Min Addl Investment | ₹1000 | ₹100 |
Launch Date | 05 Jun 2004 | 30 Nov 2018 |
Category | Pharma & Healthcare | Pharma & Healthcare |
Fund Type | Open Ended | Open Ended |
Benchmark | BSE Healthcare | BSE Healthcare |
Turn Over | 21% | 18% |
Expense Ratio | 1.82 | 1.9 |
Manager | Sailesh Raj Bhan | Jay Kothari |
ISIN Code | INF204K01968 | INF740KA1LD8 |
Exits Load | Nippon India Pharma Fund - Growth charges 1.0% of sell value; if fund sold before 30 days. There are no other charges./365 | DSP Healthcare Fund - Regular Plan - Growth charges 0.5% of sell value; if fund sold before 30 days. There are no other charges./365 |
Trailing Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Month | 3.29% | 5.6% |
6 Month | 4.92% | -0.9% |
1 Year | 12.28% | 13.13% |
3 Year | 24.18% | 25.62% |
5 Year | 21.42% | 22.93% |
SIP Return Analysis
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
6 Month | 6.54% | 5.97% |
1 Year | 6.93% | 2.98% |
3 Year | 23.39% | 23.4% |
5 Year | 19.28% | 19.63% |
Rolling Lumpsum Returns
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
1 Year | 17.67% | 26.81% |
3 Year | 20.32% | 20.65% |
5 Year | 20.52% | 27.26% |
Risk Management
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Standard Deviation | 14.75% | 14.66% |
Sharp | 1.20% | 1.25% |
Beta | 0.90% | 0.85% |
Alpha | 0.72% | 2.27% |
Still Confused Which Fund To Select? Don’t worry! We’re just a call away.
Get Free Experts Guidance
Fund Managers
Scheme Name | Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Name | Sailesh Raj Bhan | Jay Kothari |
Total AUM | ₹96086 Cr | ₹0 Cr |
Funds Managed | 5 | 20 |
Nippon India Pharma Fund-Growth Plan-Growth Option | DSP Healthcare Fund - Regular Plan - Growth |
Market Cap
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 0.53 | 14.98 |
Large Cap | 35.06 | 17.24 |
Mid Cap | 31.99 | 14.54 |
Small Cap | 32.41 | 53.24 |
Sector Allocation
Scheme Name |
Nippon India Pharma Fund-Growth Plan-Growth Option |
DSP Healthcare Fund - Regular Plan - Growth |
---|---|---|
Others | 0.53 | 1.68 |
Healthcare | 99.47 | 96.71 |
Financial Services | - | 1.61 |
Top Comparisons
HDFC Focused Fund - GROWTH PLAN
3Y Returns25.45%
360 ONE Focused Fund Regular-Growth
3Y Returns20.02%
Kotak Banking and PSU Debt - Growth
3Y Returns7.7%
Edelweiss Banking and PSU Debt Fund - Regular Plan - Growth Option
3Y Returns7.87%
Nippon India Medium Duration Fund - Growth Option
3Y Returns8.34%
Invesco India Medium Duration Fund - Regular - Growth
3Y Returns7.22%
Kotak Midcap Fund - Growth
3Y Returns25.16%
Edelweiss Mid Cap Fund - Regular Plan - Growth Option
3Y Returns28.27%